Updated: Pfizer discloses patient death in Hympavzi hemophilia trial
更新：辉瑞披露Hympavzi血友病试验中一名患者死亡

A patient in Pfizer’s trial of its hemophilia drug Hympavzi died from a thrombotic stroke, the drugmaker said Monday.
辉瑞称，周一在其血友病药物Hympavzi的试验中有一名患者死于血栓性中风。